SlideShare una empresa de Scribd logo
1 de 50
Raymond Zakhari, DNP, EdM, ANP-BC, FNP-BC, PMHNP-BC
Department of Internal Medicine in Psychiatry
New York Presbyterian Hospital Weill Cornell
www.RaymondZakhari.com
www.MetroMedicalDirect.com
 Definitions
 Drugs, Effects & Consequences
 Statistics
 Professional Responsibilities
 Treatment Options
 Dependence: indicates an altered physiologic
state caused by repeated administration of a
drug the cessation of which results in a specific
syndrome
 Abuse: use of any drug, usually by self
administration, in a manner that deviates from
approved social or medical patterns
 Misuse: usually applied to prescribed
medications that are not used properly
 The repeated and increasing use of a substance
or behavior, when deprived, causes symptoms
of distress, and an irresistible urge to use the
agent or engage in the behavior again despite
consequences (physical, social, legal).
 A substance of the specific syndrome that
occurs after stopping or reducing the amount
of substance that has been used regularly over
a prolonged period characterized by
physiological and psychological signs and
symptoms.
 Also called abstinence syndrome or discontinuation
syndrome
 A physiological phenomenon which occurs
after repeated consumption of a drug
producing decreased effect despite increasingly
larger doses to achieve the first affect.
 Behavioral tolerance reflects the ability to perform
tasks despite the effects of the drugs
 The ability of one drug to be substituted for
another each usually producing the same
physiological and psychological effects
 Benzodiazepines and barbiturates
 Neuro adaptation: Neurochemical changes in the
body that result from the repeated administration of
a drug which accounts for the phenomenon of
tolerance
 Friends or family members affected by the
behavior of a substance abuser, facilitating the
abusers addictive behavior, requires the
unwillingness of a family member to accept
addiction as a medical psychiatric disorder,
and denial that a person is abusing the
substance.
 Enabler
 A primitive defense mechanism characterized
by an unwillingness to accept ego-dystonic
obvious circumstances.
 22 million people older than the age of 12 were
classified as having a substance related
disorder
 10% of the total US population
(National Institute of Drug Abuse 2012)
 21 million (9.3%) people are diagnosed with diabetes
in the United States (CDC 2012)
 15 million were dependent on or abuse alcohol
 669,000 people were dependent on or abused
heroin
 4.3 million abused marijuana
 1 million abused cocaine
 2 million were classified as dependent on or
abused pain relievers
 Those who use any substance younger than 15
years of age for more likely to become addicted
than those who started at a later age
 Of Adults 21 and older who first tried alcohol
at age 14 or younger
 15% were classified as alcoholics
 3% who first used alcohol at age 21
 Men > Women| Whites > Blacks| Higher Edu.
> Lesser Edu.| Unemployed > employed
 It depends on the individual and the
circumstances
 It requires drug availability & social
acceptability
 Likelihood is increased with peer pressure and initial
experimentation experience
 Addiction determinant: is influenced by personality,
individual biology, actions of the drug
 From voluntary to compulsive
 Classic theories: substance abuse is a
masturbatory equivalent (heroin users
describes the initial rushes similar to a
prolonged sexual orgasm)
 Defense against anxious impulses or a
manifestation of oral regression
 Disturbed Ego function: inability to deal with
reality (self-medication).
 Behavior maintained by
its consequences
 Genetic factors: twin
studies suggested a
component for alcoholism
 Neurochemical factors:
Receptors and Receptor
Systems
 Pathways and
neurotransmitters
comprise the brain
reward circuitry
 Dopamine, GABA,
Opioids
SUBSTANCE USE
DISORDER:
 a maladaptive pattern
of use leading to
significant impairment
or distress as
manifested by 2 or more
of the following
occurring within a 12
month period
 Failure to fulfill major role
obligations
 Recurrent use and situations in
which physical hazard may
occur i.e. driving
 Continued use despite having
persistent or recurrent social or
interpersonal problems
exacerbated by effects of the
substance
 Tolerance developed
 Withdrawal
 Increasing use
 Persistent desire or unsuccessful
efforts to cut down
 Giving up important activities
for the substance use
 Continued use despite
knowledge of persistent and
 A substance specific
syndrome resulting
from the abrupt
cessation of heavy or
prolonged use of a
substance
 The development of a
syndrome due to the
cessation or reduction
in substance use that
has been heavy
 Syndrome that causes
clinically significant
distress or impairment
 Symptoms are not due
to a general medical
condition or another
mental disorder
 Antisocial Personality
Disorder
 Mood Disorders
 Anxiety Disorders
 Suicidality
 Delirium
 Psychosis
 Dementia
 Sleep Disorders
 Sexual Dysfunction
 Amnestic Disorder
 Intoxication
 Flashbacks
 Cognitive impairment
 Encephalopathies
 Hashish, Marijuana
 How Consumed: swallowed, smoked
 Effects: euphoria, slowed thinking and reaction
time, confusion, impaired balance and
coordination
 Consequences: cough, frequent respiratory
infections, impaired memory and learning,
increased heart rate, anxiety, panic attacks
 Barbiturates, Benzodiazepines, GHB, Rohypnol,
Quaalude
 How Consumed: swallowed, injected
 Effects: reduced anxiety, feeling of well-being, lowered
inhibitions, slowed pulse and breathing, lowered blood
pressure, poor concentration
 Consequences: fatigue, confusion, impaired
coordination, memory, judgment, respiratory
depression and arrest, death
 Ketamine, PCP
 How Consumed: Injected, swallowed, smoked, snorted
 Effects: increased heart rate and blood pressure,
impaired motor function, delirium, panic, aggression
 Consequences: memory loss, numbness,
nausea/vomiting, depression
 LSD, Mescaline, Mushrooms
 How Consumed: swallowed, smoked
 Effects: increased body temperature, heart rate, blood
pressure, loss of appetite, sleeplessness, numbness,
weakness, tremors, altered states of perception and
feeling, nausea
 Consequences: persisting perception disorder
(flashbacks)
 Codeine, heroin, morphine, opium,
Oxycodone, Hydrocodone
 How Consumed: injected, swallowed, smoked,
snorted
 Effects: pain relief, euphoria, drowsiness
 Consequences: nausea, constipation, confusion,
sedation, respiratory depression and arrest,
unconsciousness, coma, death
 Amphetamine, cocaine, MDMA, methamphetamine,
nicotine, Ritalin
 How Consumed: injected, smoked, snorted, swallowed
 Effects: increased heart rate, blood pressure,
metabolism, feelings of exhilaration, energy, increased
mental alertness
 Consequences: rapid or irregular heart beat, reduced
appetite, weight loss, heart failure, nervousness,
insomnia
 Open-ended questions
 Motivational Interviewing
 BATHE technique
 Obtain releases for/ from all other providers
 Maintain active communication with providers
 Observations: MSE and Physical exam findings
 Resist the righting reflex
 Psychological reactivity & Therapeutic Paradox
 Understand your patient’s motivation
 Why would they want to?
 Listen to your patient
 Equal parts of listening & informing
 Empower your patient
 Help in contemplating the how and why
 It sounds like you may benefit from talking to
someone
 Provide 2-3 referrals
 Provide the patient with reassurance that you
are referring to a resource you trust
Reflective
Listening
Validate &
Affirm
Explore a Menu
of Options
Explore the
Pro’s and
Con’s
Where are they on the SOC continuum?
Ask permissionSet an
Agenda
Ambivalence
is Normal
Resist the
Righting Reflex
Consider life balance
High Risk Situations
Explore
Coping
Create
Discrepancy
Readiness to
Change?
What is the
motivation
Abstinence
Violation
Effect
Empathy
Promote Self-
Efficacy
Use Rulers
What’s
Next?
Listen for and try to do these
things:
 Abstinence vs. harm reduction
 Detoxification
 Outpatient
 Intensive Outpatient
 Inpatient
 28/ 30-day
 Long-term residential
 Half-way house
 Anonymous meetings
Relapse Prevention Model
Raymond Zakhari The Adult Health Nurse Practitioner of New York, LLC Metro Medical Direct
 High Risk Situations
 Self-Efficacy
 Abstinence Violation Effect (AVE)
Raymond Zakhari The Adult Health Nurse Practitioner of New York, LLC Metro Medical Direct
Craving
mediated
by
Expectancies
For immediate
effect
Rationalization,
Denial, and
apparently
irrelevant
decisions
Lifestyle imbalance
(Shoulds> wants) Desire for
indulgence or
immediate
gratification (I
owe myself)
Precursors to High Risk
Situations
High Risk
Situation
Coping
Response
No Coping
Response
Increased Self-
Efficacy
Decreased
Self-Efficacy
Decreased
probability of
relapse
Lapse
Abstinence
Violation
Effect
Relapse
Cognitive Behavior Model
of the Relapse Process
Negative Emotional State (35%)
Interpersonal Conflict (16%)
Social Pressure (20%)
Cummings, Gordon, & Marlatt 1980; Marlatt & Gordon 1980
Functionality in
Family, Work,
and Community
Brain changes in addiction help explain
continued drug abuse and relapse.
Relapse Rates for Drug Addiction
are Similar to Other Chronic Medical
Conditions
0
10
20
30
40
50
60
70
80
90
100
Drug
Dependence
Type I
Diabetes
Hypertension Asthma
40to60%
30to50%
50to70%
50to70%
Source: McLellan, A.T. et al., JAMA, Vol 284(13), October
PercentofPatientsWhoRelapse
Drug Abuse Treatment Can Work
• No single treatment is
appropriate for all
individuals.
• Treatment needs to be
readily available.
• Treatment must attend to
multiple needs of the
individual, not just drug use.
• Multiple courses of
treatment may be required
for success.
• Remaining in treatment for
an adequate period of time is
critical for treatment
effectiveness.
0
2
4
6
8
10
Pre During Post
Treatment Research Institute
Outcome In Diabetes
Conclusion: Treatment Successful!
0
2
4
6
8
10
Pre During Post
Treatment Research Institute
Outcome In Addiction
(Incorrect) conclusion: Treatment NOT successful!
Intake Processing /
Assessment
Treatment Plan
Pharmacotherapy
Continuing Care
Clinical and Case
Management
Self-Help / Peer
Support Groups
Behavioral
Therapy and
Counseling
Substance Use
Monitoring
Detoxification
Child Care
Services
Vocational
Services
Medical
Services
Educational
ServicesAIDS / HIV
Services
Family
Services
Financial
Services
Legal
Services
Mental Health
Services
Housing /
Transportation
Services
Services to Match Needs
Treatment should target factors associated
with criminal behavior.
 Criminal thinking
 Antisocial values
 Anger/hostility
 Problem solving
 Conflict resolution skills
 Attitudes toward school/work
 Mental health problems
 Family functioning
 Barriers to care
 Alcohol/drug problems
DRUG ABUSE
Depression
Attention Deficit Disorder
Conduct Disorders
Bipolar Disorder
Post-Traumatic Stress Disorder
 Methadone
 Naltrexone
 Buprenorphine
 www.al-anon.alateen.org
 www.alcoholics-anonymous.org
 www.na.org
 www.nida.nih.gov
 www.samhsa.gov
 www.niaaa.nih.gov
 www.fadaa.org
Raymond Zakhari, NP
Twitter: @RZakhari
#AddictCareNYC
www.RaymondZakhari.com

Más contenido relacionado

La actualidad más candente

Substance abuse by jaber
Substance abuse by jaberSubstance abuse by jaber
Substance abuse by jaberJaber Manasia
 
Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse pptDFC2011
 
Dissociative D1isorder
Dissociative D1isorderDissociative D1isorder
Dissociative D1isorderArun Madanan
 
Neurobiological understanding of anxiety disorder
Neurobiological understanding of anxiety disorder  Neurobiological understanding of anxiety disorder
Neurobiological understanding of anxiety disorder Devashish Konar
 
Substance Use Disorder
Substance Use DisorderSubstance Use Disorder
Substance Use DisorderDeepanwita Roy
 
Types of Anxiety disorders and treatment
Types of Anxiety disorders and treatmentTypes of Anxiety disorders and treatment
Types of Anxiety disorders and treatmentSoujanya Pharm.D
 
Abnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related DisordersAbnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related DisordersSavipra Gorospe
 
Substance related disorder
Substance related disorderSubstance related disorder
Substance related disorderArchana tripathy
 
Major depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentationMajor depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentationDryogeshcsv
 
Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms
Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms
Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms Prevention Resource Center Region 8
 
Unit 9 substance use disorder
Unit 9 substance use disorderUnit 9 substance use disorder
Unit 9 substance use disorderVipin Chandran
 

La actualidad más candente (20)

Substance abuse by jaber
Substance abuse by jaberSubstance abuse by jaber
Substance abuse by jaber
 
Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse ppt
 
Addiction
AddictionAddiction
Addiction
 
Dissociative D1isorder
Dissociative D1isorderDissociative D1isorder
Dissociative D1isorder
 
Substance related disorders
Substance related disordersSubstance related disorders
Substance related disorders
 
Panic disorders
Panic disordersPanic disorders
Panic disorders
 
Neurobiological understanding of anxiety disorder
Neurobiological understanding of anxiety disorder  Neurobiological understanding of anxiety disorder
Neurobiological understanding of anxiety disorder
 
Substance Use Disorder
Substance Use DisorderSubstance Use Disorder
Substance Use Disorder
 
RELAPSE PREVENTION & EARLY INTERVENTION STRATEGIES
RELAPSE PREVENTION & EARLY INTERVENTION STRATEGIES RELAPSE PREVENTION & EARLY INTERVENTION STRATEGIES
RELAPSE PREVENTION & EARLY INTERVENTION STRATEGIES
 
Drugs of Abuse: Addiction Theory
Drugs of Abuse: Addiction TheoryDrugs of Abuse: Addiction Theory
Drugs of Abuse: Addiction Theory
 
Types of Anxiety disorders and treatment
Types of Anxiety disorders and treatmentTypes of Anxiety disorders and treatment
Types of Anxiety disorders and treatment
 
Abnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related DisordersAbnormal Psychology - Substance-Related Disorders
Abnormal Psychology - Substance-Related Disorders
 
Drug Abuse
Drug AbuseDrug Abuse
Drug Abuse
 
Psychiatric disorders
Psychiatric disordersPsychiatric disorders
Psychiatric disorders
 
Substance related disorder
Substance related disorderSubstance related disorder
Substance related disorder
 
Major depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentationMajor depressive disorder (MDD) presentation
Major depressive disorder (MDD) presentation
 
Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms
Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms
Harmful Effects of Alcohol and Substance Abuse-Signs and Symptoms
 
Mood Disorders- Psychiatric nursing
Mood Disorders- Psychiatric nursingMood Disorders- Psychiatric nursing
Mood Disorders- Psychiatric nursing
 
Unit 9 substance use disorder
Unit 9 substance use disorderUnit 9 substance use disorder
Unit 9 substance use disorder
 
Dissociative disorders cnt premnath 22 january
Dissociative disorders cnt premnath 22 januaryDissociative disorders cnt premnath 22 january
Dissociative disorders cnt premnath 22 january
 

Similar a The Psychology and Neurology of Substance Related Disorders

Substance- Related Disorders
Substance- Related DisordersSubstance- Related Disorders
Substance- Related DisordersEric Pazziuagan
 
Substance related disorders
Substance related disordersSubstance related disorders
Substance related disordersEric Pazziuagan
 
Substance-related Disorders.ppt
Substance-related Disorders.pptSubstance-related Disorders.ppt
Substance-related Disorders.pptashenafigezahegn2
 
SUBSTANCE RELbddddddddATED DISORDER.pptx
SUBSTANCE RELbddddddddATED DISORDER.pptxSUBSTANCE RELbddddddddATED DISORDER.pptx
SUBSTANCE RELbddddddddATED DISORDER.pptxsuhanimunjal27
 
Drug dependance and abuse
Drug dependance and abuseDrug dependance and abuse
Drug dependance and abuseAbhi Keralli
 
Substance Abuse, Psychiatric Nursing, B. Sc (N) PPT
Substance Abuse, Psychiatric Nursing, B. Sc (N) PPTSubstance Abuse, Psychiatric Nursing, B. Sc (N) PPT
Substance Abuse, Psychiatric Nursing, B. Sc (N) PPTNithiy Uday
 
Drug Abuse, Dependence & Addiction
Drug Abuse, Dependence & AddictionDrug Abuse, Dependence & Addiction
Drug Abuse, Dependence & AddictionAleem Ashraf
 
Drug Addiction: Signs, Symptoms, and Withdrawal Management | Solh Wellness
Drug Addiction: Signs, Symptoms, and Withdrawal Management | Solh WellnessDrug Addiction: Signs, Symptoms, and Withdrawal Management | Solh Wellness
Drug Addiction: Signs, Symptoms, and Withdrawal Management | Solh WellnessSolh Wellness
 
substance abuse in adolescents
substance abuse in adolescentssubstance abuse in adolescents
substance abuse in adolescentsUtkarsh Srivastava
 
Addiction Psychiatry
Addiction PsychiatryAddiction Psychiatry
Addiction PsychiatryJacob Kagan
 
Drugs & Society Chapter 2
Drugs & Society Chapter 2Drugs & Society Chapter 2
Drugs & Society Chapter 2Michelle Meyer
 
Non-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of AddictionsNon-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of AddictionsBrendan Quinn
 
Clinical Drug Abuse
Clinical Drug AbuseClinical Drug Abuse
Clinical Drug AbuseMasudRana461
 
Drug addiction.pptx
Drug addiction.pptxDrug addiction.pptx
Drug addiction.pptxsaad510479
 
Insel10ebrup Ppt Ch07
Insel10ebrup Ppt Ch07Insel10ebrup Ppt Ch07
Insel10ebrup Ppt Ch07lnguyen
 
Drug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay AnandDrug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay AnandAkshay Anand
 

Similar a The Psychology and Neurology of Substance Related Disorders (20)

Substance- Related Disorders
Substance- Related DisordersSubstance- Related Disorders
Substance- Related Disorders
 
Substance related disorders
Substance related disordersSubstance related disorders
Substance related disorders
 
Substance-related Disorders.ppt
Substance-related Disorders.pptSubstance-related Disorders.ppt
Substance-related Disorders.ppt
 
SUBSTANCE RELbddddddddATED DISORDER.pptx
SUBSTANCE RELbddddddddATED DISORDER.pptxSUBSTANCE RELbddddddddATED DISORDER.pptx
SUBSTANCE RELbddddddddATED DISORDER.pptx
 
Drug dependance and abuse
Drug dependance and abuseDrug dependance and abuse
Drug dependance and abuse
 
Sud 2014
Sud 2014Sud 2014
Sud 2014
 
Substance Abuse, Psychiatric Nursing, B. Sc (N) PPT
Substance Abuse, Psychiatric Nursing, B. Sc (N) PPTSubstance Abuse, Psychiatric Nursing, B. Sc (N) PPT
Substance Abuse, Psychiatric Nursing, B. Sc (N) PPT
 
Drug Abuse, Dependence & Addiction
Drug Abuse, Dependence & AddictionDrug Abuse, Dependence & Addiction
Drug Abuse, Dependence & Addiction
 
Drug Addiction: Signs, Symptoms, and Withdrawal Management | Solh Wellness
Drug Addiction: Signs, Symptoms, and Withdrawal Management | Solh WellnessDrug Addiction: Signs, Symptoms, and Withdrawal Management | Solh Wellness
Drug Addiction: Signs, Symptoms, and Withdrawal Management | Solh Wellness
 
substance abuse in adolescents
substance abuse in adolescentssubstance abuse in adolescents
substance abuse in adolescents
 
Addiction Psychiatry
Addiction PsychiatryAddiction Psychiatry
Addiction Psychiatry
 
Drugs & Society Chapter 2
Drugs & Society Chapter 2Drugs & Society Chapter 2
Drugs & Society Chapter 2
 
Non-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of AddictionsNon-Dependence Producing Drugs in the Treatment of Addictions
Non-Dependence Producing Drugs in the Treatment of Addictions
 
Clinical Drug Abuse
Clinical Drug AbuseClinical Drug Abuse
Clinical Drug Abuse
 
drugs abuse , tolerances, addiction
drugs abuse , tolerances, addiction drugs abuse , tolerances, addiction
drugs abuse , tolerances, addiction
 
Drug addiction.pptx
Drug addiction.pptxDrug addiction.pptx
Drug addiction.pptx
 
Insel10ebrup Ppt Ch07
Insel10ebrup Ppt Ch07Insel10ebrup Ppt Ch07
Insel10ebrup Ppt Ch07
 
Drug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay AnandDrug Dependence & Abuse - Presentation by Akshay Anand
Drug Dependence & Abuse - Presentation by Akshay Anand
 
Drug abuse
Drug abuseDrug abuse
Drug abuse
 
Drug and Alcohol Abuse
Drug and Alcohol AbuseDrug and Alcohol Abuse
Drug and Alcohol Abuse
 

Último

Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 

Último (20)

Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 

The Psychology and Neurology of Substance Related Disorders

  • 1. Raymond Zakhari, DNP, EdM, ANP-BC, FNP-BC, PMHNP-BC Department of Internal Medicine in Psychiatry New York Presbyterian Hospital Weill Cornell www.RaymondZakhari.com www.MetroMedicalDirect.com
  • 2.  Definitions  Drugs, Effects & Consequences  Statistics  Professional Responsibilities  Treatment Options
  • 3.  Dependence: indicates an altered physiologic state caused by repeated administration of a drug the cessation of which results in a specific syndrome
  • 4.  Abuse: use of any drug, usually by self administration, in a manner that deviates from approved social or medical patterns  Misuse: usually applied to prescribed medications that are not used properly
  • 5.  The repeated and increasing use of a substance or behavior, when deprived, causes symptoms of distress, and an irresistible urge to use the agent or engage in the behavior again despite consequences (physical, social, legal).
  • 6.  A substance of the specific syndrome that occurs after stopping or reducing the amount of substance that has been used regularly over a prolonged period characterized by physiological and psychological signs and symptoms.  Also called abstinence syndrome or discontinuation syndrome
  • 7.  A physiological phenomenon which occurs after repeated consumption of a drug producing decreased effect despite increasingly larger doses to achieve the first affect.  Behavioral tolerance reflects the ability to perform tasks despite the effects of the drugs
  • 8.  The ability of one drug to be substituted for another each usually producing the same physiological and psychological effects  Benzodiazepines and barbiturates  Neuro adaptation: Neurochemical changes in the body that result from the repeated administration of a drug which accounts for the phenomenon of tolerance
  • 9.  Friends or family members affected by the behavior of a substance abuser, facilitating the abusers addictive behavior, requires the unwillingness of a family member to accept addiction as a medical psychiatric disorder, and denial that a person is abusing the substance.  Enabler
  • 10.  A primitive defense mechanism characterized by an unwillingness to accept ego-dystonic obvious circumstances.
  • 11.  22 million people older than the age of 12 were classified as having a substance related disorder  10% of the total US population (National Institute of Drug Abuse 2012)  21 million (9.3%) people are diagnosed with diabetes in the United States (CDC 2012)
  • 12.  15 million were dependent on or abuse alcohol  669,000 people were dependent on or abused heroin  4.3 million abused marijuana  1 million abused cocaine  2 million were classified as dependent on or abused pain relievers
  • 13.  Those who use any substance younger than 15 years of age for more likely to become addicted than those who started at a later age  Of Adults 21 and older who first tried alcohol at age 14 or younger  15% were classified as alcoholics  3% who first used alcohol at age 21  Men > Women| Whites > Blacks| Higher Edu. > Lesser Edu.| Unemployed > employed
  • 14.  It depends on the individual and the circumstances  It requires drug availability & social acceptability  Likelihood is increased with peer pressure and initial experimentation experience  Addiction determinant: is influenced by personality, individual biology, actions of the drug
  • 15.  From voluntary to compulsive  Classic theories: substance abuse is a masturbatory equivalent (heroin users describes the initial rushes similar to a prolonged sexual orgasm)  Defense against anxious impulses or a manifestation of oral regression  Disturbed Ego function: inability to deal with reality (self-medication).
  • 16.  Behavior maintained by its consequences  Genetic factors: twin studies suggested a component for alcoholism  Neurochemical factors: Receptors and Receptor Systems  Pathways and neurotransmitters comprise the brain reward circuitry  Dopamine, GABA, Opioids
  • 17.
  • 18.
  • 19.
  • 20. SUBSTANCE USE DISORDER:  a maladaptive pattern of use leading to significant impairment or distress as manifested by 2 or more of the following occurring within a 12 month period  Failure to fulfill major role obligations  Recurrent use and situations in which physical hazard may occur i.e. driving  Continued use despite having persistent or recurrent social or interpersonal problems exacerbated by effects of the substance  Tolerance developed  Withdrawal  Increasing use  Persistent desire or unsuccessful efforts to cut down  Giving up important activities for the substance use  Continued use despite knowledge of persistent and
  • 21.  A substance specific syndrome resulting from the abrupt cessation of heavy or prolonged use of a substance  The development of a syndrome due to the cessation or reduction in substance use that has been heavy  Syndrome that causes clinically significant distress or impairment  Symptoms are not due to a general medical condition or another mental disorder
  • 22.  Antisocial Personality Disorder  Mood Disorders  Anxiety Disorders  Suicidality  Delirium  Psychosis  Dementia  Sleep Disorders  Sexual Dysfunction  Amnestic Disorder  Intoxication  Flashbacks  Cognitive impairment  Encephalopathies
  • 23.  Hashish, Marijuana  How Consumed: swallowed, smoked  Effects: euphoria, slowed thinking and reaction time, confusion, impaired balance and coordination  Consequences: cough, frequent respiratory infections, impaired memory and learning, increased heart rate, anxiety, panic attacks
  • 24.  Barbiturates, Benzodiazepines, GHB, Rohypnol, Quaalude  How Consumed: swallowed, injected  Effects: reduced anxiety, feeling of well-being, lowered inhibitions, slowed pulse and breathing, lowered blood pressure, poor concentration  Consequences: fatigue, confusion, impaired coordination, memory, judgment, respiratory depression and arrest, death
  • 25.  Ketamine, PCP  How Consumed: Injected, swallowed, smoked, snorted  Effects: increased heart rate and blood pressure, impaired motor function, delirium, panic, aggression  Consequences: memory loss, numbness, nausea/vomiting, depression
  • 26.  LSD, Mescaline, Mushrooms  How Consumed: swallowed, smoked  Effects: increased body temperature, heart rate, blood pressure, loss of appetite, sleeplessness, numbness, weakness, tremors, altered states of perception and feeling, nausea  Consequences: persisting perception disorder (flashbacks)
  • 27.  Codeine, heroin, morphine, opium, Oxycodone, Hydrocodone  How Consumed: injected, swallowed, smoked, snorted  Effects: pain relief, euphoria, drowsiness  Consequences: nausea, constipation, confusion, sedation, respiratory depression and arrest, unconsciousness, coma, death
  • 28.  Amphetamine, cocaine, MDMA, methamphetamine, nicotine, Ritalin  How Consumed: injected, smoked, snorted, swallowed  Effects: increased heart rate, blood pressure, metabolism, feelings of exhilaration, energy, increased mental alertness  Consequences: rapid or irregular heart beat, reduced appetite, weight loss, heart failure, nervousness, insomnia
  • 29.  Open-ended questions  Motivational Interviewing  BATHE technique  Obtain releases for/ from all other providers  Maintain active communication with providers  Observations: MSE and Physical exam findings
  • 30.  Resist the righting reflex  Psychological reactivity & Therapeutic Paradox  Understand your patient’s motivation  Why would they want to?  Listen to your patient  Equal parts of listening & informing  Empower your patient  Help in contemplating the how and why
  • 31.  It sounds like you may benefit from talking to someone  Provide 2-3 referrals  Provide the patient with reassurance that you are referring to a resource you trust
  • 32. Reflective Listening Validate & Affirm Explore a Menu of Options Explore the Pro’s and Con’s Where are they on the SOC continuum? Ask permissionSet an Agenda Ambivalence is Normal Resist the Righting Reflex Consider life balance High Risk Situations Explore Coping Create Discrepancy Readiness to Change? What is the motivation Abstinence Violation Effect Empathy Promote Self- Efficacy Use Rulers What’s Next? Listen for and try to do these things:
  • 33.  Abstinence vs. harm reduction  Detoxification  Outpatient  Intensive Outpatient  Inpatient  28/ 30-day  Long-term residential  Half-way house  Anonymous meetings
  • 34. Relapse Prevention Model Raymond Zakhari The Adult Health Nurse Practitioner of New York, LLC Metro Medical Direct
  • 35.  High Risk Situations  Self-Efficacy  Abstinence Violation Effect (AVE) Raymond Zakhari The Adult Health Nurse Practitioner of New York, LLC Metro Medical Direct
  • 36. Craving mediated by Expectancies For immediate effect Rationalization, Denial, and apparently irrelevant decisions Lifestyle imbalance (Shoulds> wants) Desire for indulgence or immediate gratification (I owe myself) Precursors to High Risk Situations
  • 37. High Risk Situation Coping Response No Coping Response Increased Self- Efficacy Decreased Self-Efficacy Decreased probability of relapse Lapse Abstinence Violation Effect Relapse Cognitive Behavior Model of the Relapse Process
  • 38. Negative Emotional State (35%) Interpersonal Conflict (16%) Social Pressure (20%) Cummings, Gordon, & Marlatt 1980; Marlatt & Gordon 1980
  • 40. Brain changes in addiction help explain continued drug abuse and relapse.
  • 41. Relapse Rates for Drug Addiction are Similar to Other Chronic Medical Conditions 0 10 20 30 40 50 60 70 80 90 100 Drug Dependence Type I Diabetes Hypertension Asthma 40to60% 30to50% 50to70% 50to70% Source: McLellan, A.T. et al., JAMA, Vol 284(13), October PercentofPatientsWhoRelapse
  • 42. Drug Abuse Treatment Can Work • No single treatment is appropriate for all individuals. • Treatment needs to be readily available. • Treatment must attend to multiple needs of the individual, not just drug use. • Multiple courses of treatment may be required for success. • Remaining in treatment for an adequate period of time is critical for treatment effectiveness.
  • 43. 0 2 4 6 8 10 Pre During Post Treatment Research Institute Outcome In Diabetes Conclusion: Treatment Successful!
  • 44. 0 2 4 6 8 10 Pre During Post Treatment Research Institute Outcome In Addiction (Incorrect) conclusion: Treatment NOT successful!
  • 45. Intake Processing / Assessment Treatment Plan Pharmacotherapy Continuing Care Clinical and Case Management Self-Help / Peer Support Groups Behavioral Therapy and Counseling Substance Use Monitoring Detoxification Child Care Services Vocational Services Medical Services Educational ServicesAIDS / HIV Services Family Services Financial Services Legal Services Mental Health Services Housing / Transportation Services Services to Match Needs
  • 46. Treatment should target factors associated with criminal behavior.  Criminal thinking  Antisocial values  Anger/hostility  Problem solving  Conflict resolution skills  Attitudes toward school/work  Mental health problems  Family functioning  Barriers to care  Alcohol/drug problems
  • 47. DRUG ABUSE Depression Attention Deficit Disorder Conduct Disorders Bipolar Disorder Post-Traumatic Stress Disorder
  • 49.  www.al-anon.alateen.org  www.alcoholics-anonymous.org  www.na.org  www.nida.nih.gov  www.samhsa.gov  www.niaaa.nih.gov  www.fadaa.org
  • 50. Raymond Zakhari, NP Twitter: @RZakhari #AddictCareNYC www.RaymondZakhari.com